[1] Durante C, Grani G, Lamartina L, et al.The diagnosis and management of thyroid nodules: A review[J]. JAMA, 2018, 319(9): 914-924. [2] Alsubaie R, Al Amer A, Al Najjar OA, et al.Malignancy rates in thyroid imaging reporting and data system category 3 (TI-RADS 3) thyroid nodules: A retrospective study[J]. Cureus, 2023, 15(11): e48705. [3] Sinha RA, Yen PM.Metabolic messengers: Thyroid hormones[J]. Nat Metab, 2024, 6(4): 639-650. [4] 季明, 张楷, 邹子鸣, 等. 6 096例健康体检教师人群甲状腺结节检出率及影响因素分析[J]. 南京医科大学学报(自然科学版), 2022, 42(9): 1287-1293. [5] 赖婧玥, 高楠, 冉晓丽, 等. 西安地区体检人群甲状腺疾病患病情况及影响因素分析[J]. 华南预防医学, 2023, 49(10): 1305-1308. [6] 朱路, 李冠澎, 湛梓剑, 等. 糖化血红蛋白在身体质量指数与甲状腺结节患病关联作用的中介效应研究[J]. 现代预防医学, 2025, 52(4): 742-748. [7] Kwak JY, Han KH, Yoon HJ, et al.Thyroid imaging reporting and data system for US features of nodules: A step in establishing better stratification of cancer risk[J]. Radiology, 2011, 260(3): 892-899. [8] Qu MY, Tang W, Cui XY, et al.Increased prevalence of thyroid nodules across nearly 10 years in Shanghai, China[J]. Curr Med Sci, 2023, 43(1): 191-197. [9] Acosta GJ, Singh Ospina N, Brito JP.Epidemiologic changes in thyroid disease[J]. Curr Opin Endocrinol Diabetes Obes, 2024, 31(5): 184-190. [10] 戴国奎, 张玉振, 关若萍, 等. 广州地区公职人员甲状腺结节检出情况及影响因素分析[J]. 国际医药卫生导报, 2021, 27(23): 3662-3665. [11] 张明明, 闫柯, 蒿花, 等. 西北地区甲状腺结节与中心性肥胖代谢指标相关性的横断面研究[J]. 实用医学杂志, 2025, 41(23): 3767-3772. [12] 潘欣予, 曹宏, 梁佳, 等. 健康人群甲状腺结节的影响因素及IGF-1在甲状腺组织中的表达及临床意义[J]. 武汉大学学报(医学版), 2025, 46(6): 743-748, 805. [13] Ma CY, Liang XY, Ran L, et al.Prevalence and risk factors of thyroid nodules in breast cancer women with different clinicopathological characteristics: A cross-sectional study[J]. Clin Transl Oncol, 2024, 26(9): 2380-2387. [14] 王晓庆, 贺京军, 李一锋, 等. 健康体检人群甲状腺结节多普勒超声检查结果及影响因素分析[J]. 现代生物医学进展, 2022, 22(1): 182-186. [15] 朱炜琴, 王洋, 季勇, 等. 健康体检人群甲状腺结节现状及相关性研究[J]. 中华保健医学杂志, 2024, 26(5): 687-690. [16] Meng C, Yang P, Wang Y, et al.Prevalence and related factors of thyroid nodules in physical examination population in a level-A hospital in Jinan[J]. J Multidiscip Healthc, 2024, 17: 3753-3762. [17] Wan Z, Li Y, Dong X, et al.Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: A cross-sectional study[J]. Eur Thyroid J, 2023, 12(6): e230168. [18] 张文霞, 张琦, 黄皎, 等. 体检人群代谢综合征与甲状腺结节的相关性[J]. 中国卫生统计, 2025, 42(2): 230-234, 239. [19] 贤晓敏, 余文韬, 杜隆德, 等. 深圳地区甲状腺结节检出率与血脂、BMI的相关性分析[J]. 临床内科杂志, 2024, 41(8): 563-565. [20] 张明明, 闫柯, 李鑫, 等. 西安地区ACR TI-RADS 4类及以上甲状腺结节超声检出现状及其与代谢指标相关性研究[J]. 陕西医学杂志, 2026, 55(3): 339-343, 349. [21] Xu J, Lau P, Ma Y, et al.Prevalence and associated factors of thyroid nodules among 52 003 Chinese 'healthy' individuals in Beijing: A retrospective cross-sectional study[J]. Risk Manag Healthc Policy, 2024, 17: 181-189. [22] Wang P, Zhang H, Wang J, et al.Metabolic disease and risk of thyroid disease: Evidence from the national nurse health cohort in China[J]. Biol Res Nurs, 2023, 25(4): 627-634. [23] 刘岳楠, 渠鹏霞, 李静, 等. 基于倾向性评分匹配法探究空腹血糖对甲状腺结节发病风险的影响[J]. 安徽医药, 2026, 30(4): 738-744. [24] 黄娟娟, 刘从兵, 单思维, 许伟. 1 974例健康体检者甲状腺结节检出情况及影响因素[J]. 华南预防医学, 2022, 48(10): 1275-1278. [25] Liang Q, Yang Y, Wei A, et al.Association between depressive symptoms and thyroid nodule incidence in women: A prospective observational study[J]. BMC Public Health, 2025, 25(1): 1186. |